Quaranta V, Indiveri F, Glassy M C, Ng A, Russo C, Molinaro G A, Pellegrino M A, Ferrone S
Hum Immunol. 1980 Oct;1(3):211-23. doi: 10.1016/0198-8859(80)90016-6.
Serological and immunochemical studies showed that monoclonal antibody Q2/70 (MoAb Q2/70), produced by the hybridoma technique, is specific for human Ia-like antigens. This antibody recognizes an antigenic determinant which is different from those defining the serologic polymorphism of Ia-like antigens, and is expressed on subsets of human Ia-like molecules and on lymphoid cells from other species. MoAb Q2/70 inhibits unidirectional MLRs* between allogenic human lymphocytes, but not between murine and human lymphocytes. In ADCC* assays. MoAb Q2/70 mediates lysis of cultured human B lymphoid cells RPMI 4098, effected by murine splenocytes. The antibody is suitable to isolate immunologically functional B lymphocytes from human peripheral blood.
血清学和免疫化学研究表明,通过杂交瘤技术产生的单克隆抗体Q2/70(MoAb Q2/70)对人Ia样抗原具有特异性。该抗体识别一种抗原决定簇,它不同于那些定义Ia样抗原血清学多态性的抗原决定簇,并且在人Ia样分子的亚群以及来自其他物种的淋巴细胞上表达。MoAb Q2/70抑制同种异体人淋巴细胞之间的单向混合淋巴细胞反应(MLRs*),但不抑制小鼠和人淋巴细胞之间的反应。在抗体依赖的细胞介导的细胞毒性(ADCC*)试验中,MoAb Q2/70介导由小鼠脾细胞对培养的人B淋巴细胞RPMI 4098的裂解作用。该抗体适用于从人外周血中分离具有免疫功能的B淋巴细胞。